US Broker Ratings

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Growth with a 5.92% Upside Potential

Envista Holdings Corporation (NYSE: NVST) stands as a noteworthy player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $3.45 billion, Envista..

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Exploring a 16.7% Potential Upside in the Biotech Space

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology industry with a market capitalization of $4.2 billion, continues to capture investor interest with its innovative focus on central..

Ligand Pharmaceuticals (LGND): Investor Outlook with a 20.58% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is making waves in the biotechnology sector, and recent data suggests it might be an intriguing opportunity for investors. With its robust market cap of..

Disc Medicine, Inc. (IRON) Stock Analysis: A Strong Buy with 28.88% Potential Upside

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, stands out in the biotechnology sector as it advances novel treatments for serious hematologic diseases. With a current market cap of..

Privia Health Group, Inc. (PRVA) Stock Analysis: A Look at Strong Revenue Growth and Analyst Confidence

Privia Health Group, Inc. (NASDAQ: PRVA) operates within the healthcare sector, specifically in health information services, providing a suite of services aimed at enabling physicians to focus on patient care..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Exploring a Potential 53.62% Upside

Catalyst Pharmaceuticals, Inc. (CPRX) presents an intriguing opportunity for investors, with analysts predicting a potential upside of 53.62%. This biopharmaceutical company, valued at $2.79 billion, focuses on rare disease treatments..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Promising 62% Upside for Biotechnology Investors

Amicus Therapeutics, Inc. (FOLD), a key player in the biotechnology sector, is capturing the attention of investors with its focus on treating rare diseases. The company, headquartered in Princeton, New..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 15.20% Potential Upside Amid Healthcare Innovations

Progyny, Inc. (NASDAQ: PGNY), a leading name in the healthcare sector, particularly in healthcare plans, is drawing considerable attention from investors due to its innovative approach to fertility and family-building..

Scholar Rock Holding Corp (SRRK) Stock Analysis: Biotech Play with 12.73% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing attention in the biotech investment community with a compelling proposition for growth. With a focus on developing innovative treatments for serious diseases..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: 26% Potential Upside and Strong Analyst Support

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector, specializes in medical instruments and supplies tailored for vascular surgery. Headquartered in Burlington, Massachusetts, LeMaitre Vascular offers a..

CG Oncology, Inc. (CGON) Stock Analysis: Investors Eye a 63.63% Upside in the Biotech Sector

CG Oncology, Inc. (NASDAQ: CGON), a prominent player in the healthcare sector, specifically within biotechnology, has been drawing significant attention from investors. With a current market capitalization of $3.49 billion,..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Exploring a Promising 26.85% Upside Potential

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a neuroscience-focused biopharmaceutical company headquartered in Burnaby, Canada, is garnering significant attention in the biotechnology sector. Known for its pioneering work in developing treatments for..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Navigating a 50% Potential Upside Amidst Market Volatility

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands out in the healthcare sector, particularly within the medical care facilities industry, as it continues to cater to the behavioral healthcare and recovery..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 43.52% Potential Upside in Biotech

Vericel Corporation (NASDAQ: VCEL), a notable player in the biotechnology sector, is capturing the interest of investors with its impressive potential for growth. With a current market capitalization of $1.96..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Strong Buy Ratings Signal Potential 25.69% Upside

Mirum Pharmaceuticals, Inc. (MIRM), a biopharmaceutical company headquartered in Foster City, California, is capturing the attention of investors with its promising portfolio and robust analyst endorsements. Specializing in the healthcare..

Addus HomeCare Corporation (ADUS) Stock Analysis: A Potential 17% Upside in the Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS) is drawing significant attention from investors within the healthcare sector, primarily due to its robust growth potential and promising analyst ratings. With a market capitalization..

Kymera Therapeutics (KYMR): Analyst Consensus Signals 16% Upside in Innovative Biotech Space

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a trailblazer in the biotechnology sector, is gaining attention from investors with its innovative approach to drug development. The company, headquartered in Watertown, Massachusetts, specializes..

Immunovant, Inc. (IMVT) Stock Analysis: Unpacking a 70% Upside Potential

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biotechnology company, is increasingly becoming a focal point for investors seeking opportunities in the healthcare sector. With a substantial market capitalization of $3.99 billion,..

Merus N.V. (MRUS) Stock Analysis: Navigating the Biotech Landscape with 1.10% Potential Upside

Merus N.V. (NASDAQ: MRUS), a prominent player in the biotechnology sector, is gaining attention in the investment community. With a current market capitalization of $7.28 billion, this Netherlands-based clinical-stage immuno-oncology..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Steady Performer in the Genomics Space with 51.9% Revenue Growth

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, continues to make notable strides in the genomics space. Based in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds